TXNIP and diabetic kidney disease: Thioredoxin-interacting protein (Txnip, 4.4-fold upregulated) has been implicated in the pathogenesis of diabetic nephropathy [33], and may mediate the ROS-dependent adverse effects of hyperglycemia on mesangial cells in vitro [34].